Skip Navigation


Hum. Reprod. Advance Access originally published online on May 20, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/7/1629    most recent
deh254v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Noguchi, S.
Right arrow Articles by Hiramatsu, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noguchi, S.
Right arrow Articles by Hiramatsu, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 19, No. 7, 1629-1632, July 2004
© 2004 European Society of Human Reproduction and Embryology

Use of artificial dermis and recombinant basic fibroblast growth factor for creating a neovagina in a patient with Mayer–Rokitansky–Küster–Hauser syndrome

Soichi Noguchi1,2, Mikiya Nakatsuka1, Yuka Sugiyama1, Chebib Chekir1, Yasuhiko Kamada1 and Yuji Hiramatsu1

1 Department of Obstetrics and Gynecology, Okayama University Medical School, 2-5-1 Shikata, Okayama-city, Okayama 700-8558, Japan

2 To whom correspondence should be addressed. e-mail: soichi{at}d2.dion.ne.jp

Vaginal agenesis is an uncommon, but not rare, condition. Although there are many methods for creating a neovagina, the optimal treatment is unknown. An 18-year-old woman with Mayer–Rokitansky–Küster–Hauser syndrome received vaginoplasty with a modified Wharton procedure using an artificial dermis (atelocollagen sponge). From 10 days after the operation, the patient was administered human recombinant basic fibroblast growth factor (bFGF) spray to accelerate epithelialization on the neovagina. At 50 days after the operation, we confirmed histological squamous epithelialization of the vaginal epithelium. At 12 months after the operation, the neovagina was at least 3.5 cm in width and ~8 cm in length. In this case, use of artificial dermis and recombinant bFGF to create a neovagina was an easy, less invasive and useful method.

Key words: artificial dermis/bFGF/vaginoplasty/Mayer–Rokitansky–Küster–Hauser syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
P. B. Panici, F. Bellati, T. Boni, F. Francescangeli, L. Frati, and C. Marchese
Vaginoplasty using autologous in vitro cultured vaginal tissue in a patient with Mayer-von-Rokitansky-Kuster-Hauser syndrome
Hum. Reprod., July 1, 2007; 22(7): 2025 - 2028.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Giannesi, P. Marchiole, M. Benchaib, M. Chevret-Measson, P. Mathevet, and D. Dargent
Sexuality after laparoscopic Davydov in patients affected by congenital complete vaginal agenesis associated with uterine agenesis or hypoplasia
Hum. Reprod., October 1, 2005; 20(10): 2954 - 2957.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.